OssDsign AB signs business partner agreement with Muranaka M
STOCKHOLM, Aug. 11, 2020 /PRNewswire/ -- OssDsign AB (Publ) ("OssDsign") today announced that the company has signed a business partner agreement with Muranaka Medical Instruments Co., Ltd., ("Muranaka"), a pre-eminent medical product distributor in Japan. Muranaka will represent OssDsign commercially in Japan, driving adoption and sales of OssDsign's regenerative implants for cranial reconstruction.
Launching OssDsign Cranial in Japan with a national business partner is a key priority for OssDsign in 2020. The distribution agreement with Muranaka means that the company has reached a major milestone, and mutual launch preparations are now being initiated.
Muranaka, founded as a family-owned company in 1903, is the largest medical product distributor in Japan with 450 employees and presence at every hospital and clinic in the country. The company has specialist capabilities in neurosurgical supplies, and a proven track-record from promoting advanced medical devices in Japan.Muranaka and OssDsign will now jointly prepare for the upcoming market launch of OssDsign Cranial PSI, the first product of its kind to become available on the market for cranial reconstruction in Japan. OssDsign Cranial PSI is already approved by the Japanese regulatory authorities and national reimbursement has been granted from June 1, 2020. As part of the pre-launch activities, surgeries with OssDsign Cranial PSI have been performed in Japan under ethical approval and the results have been presented by prominent Japanese neurosurgeons. "We are truly excited to join forces with such a pre-eminent partner as Muranaka", says Anders Lundqvist, CEO of OssDsign. "Muranaka brings valuable experience as well as relations with important opinion leaders and customers which will add substantial strength to our business partnership. I am confident that we will be able to jointly create and expand a new market space for OssDsign's product range in Japan".
Masato Watanabe, Executive Director of Muranaka says "We have a long tradition and experience from representing manufacturers of innovative neurosurgery products in the Japanese market. OssDsign Cranial PSI has unique benefits, and based on the positive feedback from Japanese surgeons, during pre-launch clinical experiences, we are very confident that there is a strong demand for the product . We are very much looking forward to get started with this new business partnership and enabling Japanese patients to access this unique technology."
For further information, please contact:
Anders Lundqvist, CEO, OssDsign AB
Tel: +46 73 206 98 08
Email: [email protected]
Erik Penser Bank AB is the company's Certified Adviser. Contact information: Erik Penser Bank AB, Box 7405, 103 91 Stockholm, Sweden, phone: +46 (0)8-463 80 00, email: [email protected].
OssDsign is a Swedish medical technology company that develops and manufactures regenerative implants for improved healing of bone defects. Providing neuro and plastic surgeons with innovative implants, OssDsign improves the outcome for patients with severe cranial and facial defects worldwide. By combining clinical knowledge with proprietary technology, OssDsign manufactures and sells a growing range of patient-specific solutions for treating cranial defects and facial reconstruction. OssDsign's technology is the result of collaboration between clinical researchers at Karolinska University Hospital in Stockholm and material scientists at the Ångström Laboratory at Uppsala University.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
https://mb.cision.com/Main/18020/3166647/1289505.pdf OssDsign business partner in Japan
SOURCE OssDsign AB